Free Trial
NASDAQ:EUDA

EUDA Health (EUDA) Stock Price, News & Analysis

EUDA Health logo
$2.60 +0.03 (+1.17%)
Closing price 08/14/2025 03:59 PM Eastern
Extended Trading
$2.62 +0.02 (+0.77%)
As of 08/14/2025 04:10 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

About EUDA Health Stock (NASDAQ:EUDA)

Key Stats

Today's Range
$2.60
$2.60
50-Day Range
$2.52
$3.74
52-Week Range
$2.20
$6.30
Volume
1,739 shs
Average Volume
89,495 shs
Market Capitalization
$96.62 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
Strong Buy

Company Overview

EUDA Health Stock Analysis - MarketRank™

See Top-Rated MarketRank™ Stocks
23rd Percentile Overall Score

EUDA MarketRank™: 

EUDA Health scored higher than 23% of companies evaluated by MarketBeat, and ranked 848th out of 935 stocks in the medical sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

  • Earnings Growth

    Earnings for EUDA Health are expected to grow in the coming year, from ($0.33) to ($0.09) per share.

  • Percentage of Shares Shorted

    0.05% of the float of EUDA Health has been sold short.
  • Short Interest Ratio / Days to Cover

    EUDA Health has a short interest ratio ("days to cover") of 0.1, which is generally considered an acceptable ratio of short interest to trading volume.
  • Change versus previous month

    Short interest in EUDA Health has recently decreased by 13.13%, indicating that investor sentiment is improving significantly.
  • Dividend Yield

    EUDA Health does not currently pay a dividend.

  • Dividend Growth

    EUDA Health does not have a long track record of dividend growth.

  • Percentage of Shares Shorted

    0.05% of the float of EUDA Health has been sold short.
  • Short Interest Ratio / Days to Cover

    EUDA Health has a short interest ratio ("days to cover") of 0.1, which is generally considered an acceptable ratio of short interest to trading volume.
  • Change versus previous month

    Short interest in EUDA Health has recently decreased by 13.13%, indicating that investor sentiment is improving significantly.
  • News Sentiment

    EUDA Health has a news sentiment score of 0.98. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a higher news sentiment than the 0.61 average news sentiment score of Medical companies.
  • News Coverage This Week

    MarketBeat has tracked 3 news articles for EUDA Health this week, compared to 0 articles on an average week.
  • Insider Buying vs. Insider Selling

    In the past three months, EUDA Health insiders have not sold or bought any company stock.

  • Percentage Held by Institutions

    Only 4.35% of the stock of EUDA Health is held by institutions.

  • Read more about EUDA Health's insider trading history.
Receive EUDA Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for EUDA Health and its competitors with MarketBeat's FREE daily newsletter.

EUDA Stock News Headlines

EUDA Health Holdings Secures $10 Million Convertible Note Agreement
Alex’s “Next Magnificent Seven” stocks
The original “Magnificent Seven” turned $7K into $1.18 million. Now, Alex Green has identified AI’s Next Magnificent Seven—seven stocks he believes could deliver similar gains in under six years. His full breakdown is now live.
See More Headlines

EUDA Stock Analysis - Frequently Asked Questions

EUDA Health's stock was trading at $4.47 on January 1st, 2025. Since then, EUDA shares have decreased by 41.8% and is now trading at $2.60.

Shares of EUDA stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Based on aggregate information from My MarketBeat watchlists, some other companies that EUDA Health investors own include Aptorum Group (APM), Avalo Therapeutics (AVTX), Coya Therapeutics (COYA), Deswell Industries (DSWL), Dawson Geophysical (DWSN), GT Biopharma (GTBP) and iClick Interactive Asia Group (ICLK).

Company Calendar

Today
8/14/2025
Fiscal Year End
12/31/2025

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Sector
Medical
Industry
MEDICAL INFO SYS
Sub-Industry
Healthcare
Current Symbol
NASDAQ:EUDA
CIK
1847846
Employees
2
Year Founded
N/A

Profitability

EPS (Trailing Twelve Months)
N/A
Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
N/A
Net Margins
N/A
Pretax Margin
N/A
Return on Equity
N/A
Return on Assets
N/A

Debt

Debt-to-Equity Ratio
N/A
Current Ratio
0.18
Quick Ratio
0.15

Sales & Book Value

Annual Sales
$4.01 million
Price / Sales
24.09
Cash Flow
N/A
Price / Cash Flow
N/A
Book Value
($0.07) per share
Price / Book
-37.14

Miscellaneous

Outstanding Shares
37,160,000
Free Float
N/A
Market Cap
$96.62 million
Optionable
Not Optionable
Beta
-0.06
7 Stocks That Could Be Bigger Than Tesla, Nvidia, and Google Cover

Looking for the next FAANG stock before everyone has heard about it? Enter your email address to see which stocks MarketBeat analysts think might become the next trillion dollar tech company.

Get This Free Report

This page (NASDAQ:EUDA) was last updated on 8/15/2025 by MarketBeat.com Staff
From Our Partners